|
Name |
Mojavensin A
|
Molecular Formula | C50H77N13O14 | |
IUPAC Name* |
3-[(3S,6S,9R,12R,19S,22S,25S)-6,12,19,22-tetrakis(2-amino-2-oxoethyl)-9-[(4-hydroxyphenyl)methyl]-16-(9-methylundecyl)-2,5,8,11,14,18,21,24-octaoxo-1,4,7,10,13,17,20,23-octazabicyclo[23.3.0]octacosan-3-yl]propanamide
|
|
SMILES |
CCC(C)CCCCCCCCC1CC(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)CC(=O)N)CCC(=O)N)CC(=O)N)CC3=CC=C(C=C3)O)CC(=O)N
|
|
InChI |
InChI=1S/C50H77N13O14/c1-3-27(2)11-8-6-4-5-7-9-12-29-22-43(70)57-33(23-39(52)66)46(73)59-32(21-28-14-16-30(64)17-15-28)45(72)61-35(25-41(54)68)47(74)58-31(18-19-38(51)65)50(77)63-20-10-13-37(63)49(76)62-36(26-42(55)69)48(75)60-34(24-40(53)67)44(71)56-29/h14-17,27,29,31-37,64H,3-13,18-26H2,1-2H3,(H2,51,65)(H2,52,66)(H2,53,67)(H2,54,68)(H2,55,69)(H,56,71)(H,57,70)(H,58,74)(H,59,73)(H,60,75)(H,61,72)(H,62,76)/t27?,29?,31-,32+,33+,34-,35-,36-,37-/m0/s1
|
|
InChIKey |
CMYBONFRMPHHAP-IRSDMODVSA-N
|
|
Synonyms |
Mojavensin A
|
|
CAS | NA | |
PubChem CID | 102599619 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 1084.2 | ALogp: | -2.3 |
HBD: | 13 | HBA: | 14 |
Rotatable Bonds: | 23 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 460.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 77 | QED Weighted: | 0.049 |
Caco-2 Permeability: | -4.908 | MDCK Permeability: | 0.00004660 |
Pgp-inhibitor: | 0.018 | Pgp-substrate: | 0.999 |
Human Intestinal Absorption (HIA): | 0.058 | 20% Bioavailability (F20%): | 1 |
30% Bioavailability (F30%): | 1 |
Blood-Brain-Barrier Penetration (BBB): | 0.008 | Plasma Protein Binding (PPB): | 34.27% |
Volume Distribution (VD): | 0.499 | Fu: | 42.61% |
CYP1A2-inhibitor: | 0 | CYP1A2-substrate: | 0.001 |
CYP2C19-inhibitor: | 0.009 | CYP2C19-substrate: | 0.013 |
CYP2C9-inhibitor: | 0.125 | CYP2C9-substrate: | 0.023 |
CYP2D6-inhibitor: | 0 | CYP2D6-substrate: | 0.013 |
CYP3A4-inhibitor: | 0.034 | CYP3A4-substrate: | 0.003 |
Clearance (CL): | 1.365 | Half-life (T1/2): | 0.186 |
hERG Blockers: | 0.004 | Human Hepatotoxicity (H-HT): | 0.345 |
Drug-inuced Liver Injury (DILI): | 0.007 | AMES Toxicity: | 0.012 |
Rat Oral Acute Toxicity: | 0.853 | Maximum Recommended Daily Dose: | 0.933 |
Skin Sensitization: | 0.09 | Carcinogencity: | 0.414 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.001 |
Respiratory Toxicity: | 0.033 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003171 | 0.930 | D09PZZ | 0.477 | ||||
ENC003247 | 0.881 | D0M3FJ | 0.465 | ||||
ENC002094 | 0.866 | D0N4OW | 0.463 | ||||
ENC001950 | 0.852 | D0U7SH | 0.461 | ||||
ENC001506 | 0.721 | D0P4VX | 0.450 | ||||
ENC005271 | 0.486 | D0H3MG | 0.434 | ||||
ENC001088 | 0.472 | D08FJL | 0.413 | ||||
ENC005273 | 0.465 | D09OOV | 0.405 | ||||
ENC005275 | 0.454 | D02SBQ | 0.401 | ||||
ENC005274 | 0.449 | D0D8XY | 0.389 |